Evidence map›Paper›PMID 39577096›Full record

ArticleRevista medica del Instituto Mexicano del Seguro Social2024

[Dengue, rabies and measles in the post-COVID-19 pandemic era].

Alfonso Vallejos-Parás, David Alejandro Cabrera-Gaytán

Abstract readEnglish Abstract
In one paragraph

Article in Revista medica del Instituto Mexicano del Seguro Social, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Alfonso Vallejos-ParásInstituto Mexicano del Seguro Social, Coordinación de Vigilancia Epidemiológica, División de Vigilancia Epidemiológica de Enfermedades Transmisibles. Ciudad de México, México.ORCID 0000-0003-0972-8295
David Alejandro Cabrera-GaytánInstituto Mexicano del Seguro Social, Coordinación de Calidad de Insumos y Laboratorios Especializados. Ciudad de México, México.ORCID 0000-0001-5314-4786

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

After the COVID-19 pandemic, efforts have gradually been focused on medical care, epidemiological surveillance, and preventive health programs. An example of this is the identification during 2023 by the Epidemiological Surveillance System [of Mexico] of the increase in dengue cases and the presence of serotype 3, as well as cases of measles (imported and related to importation) and, at the same time, cases of human rabies with transmission from pet animals. Mexico's health system has been characterized by achievements in vaccine-preventable pathologies, as well as the robust epidemiological surveillance system for febrile exanthematous illness and vector-transmitted diseases. In this essay, the previous and current situation of selected diseases in Mexico in the post-pandemic stage of COVID-19 is presented.

Indexed as

COVID-19DengueMeaslesRabiesHumansMexicoPandemicsCOVID-19DengueEpidemiological SurveillanceMeaslesRabies

Identifiers

PMID39577096
PMCPMC12490880

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.